Dupixenteurope The dominant search intent is to understand the nature and classification of Dupixent (dupilumab), specifically whether it is a peptide. The SERP results overwhelmingly indicate that Dupixent is a monoclonal antibody, a type of biologic drug, which is distinct from a peptide in its structure and function, though it may degrade into peptides.
Tier 1:
* Core Entity: Dupixent (dupilumab)
* High-Relevance Phrases: is a monoclonal antibody, is a biologic medication, degrade to small peptides, targets interleukin
Tier 2:
* Related Entities/Concepts: IL-4, IL-13, atopic dermatitis, asthma, nasal polyps, chronic rhinosinusitis, injectable prescription medication, human monoclonal IgG4 antibody, interleukin-4 receptor alpha antagonist
* Attributes/Distinctions: non-immunosuppressive, not a steroid
* Degradation Products: amino acids
Tier 3:
* Commercial/Navigational Terms: DUPIXENTmanufacturer, Dupixentprice, Dupixenteurope, DupixentHong Kong, DupixentHong Kong price, FDADUPIXENT, PBS listing of Dupixent
* Redundant/Awkward Phrases: Type.Dupixent is a biologic medication. Its generic name is dupilumab. It belongs to a drug class known as monoclonal antibodies. Peptide (from KEGG DRUG entry, but contradicts overwhelming evidence), Amino Acid, Peptide, or Protein (general classification that can be misleading in this context)
---
Dupixent, with the generic name dupilumab, is a highly specific medication used to treat various inflammatory conditions, including moderate-to-severe atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps.Assessment report - Dupixent - EMA - European Union While the question "is Dupixent a peptide" arises, it's crucial to understand that Dupixent is fundamentally a monoclonal antibody, a sophisticated type of biologic medication, rather than a peptide.作者：D D’Ippolito·2018·被引用次数：103—The metabolic pathway of dupilumab has not been characterized.Dupilumab is expected to be degraded into small peptidesand amino acids via catabolic pathways ... Although it is expected to degrade into small peptides and amino acids in the body, its primary therapeutic function is derived from its complex protein structure as an antibody.
Dupilumab is classified as a fully human monoclonal antibodyDUPIXENT (dupilumab) Injection is ... As a human monoclonal. IgG4 antibody,dupilumab is expected to be degraded into small peptidesand amino acids.. This means it is a protein engineered in a laboratory to target and neutralize specific molecules involved in the body's inflammatory pathways.Asthma Patient Oral Steroid Education | DUPIXENT® (dupilumab) Specifically, Dupixent works by blocking the signaling of interleukin-4 (IL-4) and interleukin-13 (IL-13). These two proteins are key drivers of type 2 inflammation, which plays a significant role in conditions like atopic dermatitis and asthma. By inhibiting these interleukins through their receptor (IL-4 receptor alpha), Dupixent effectively dampens the inflammatory response without acting as an immunosuppressant or a steroid.
To clarify Dupixent's classification, it's helpful to understand the differences between these biological molecules:
* Peptides: These are short chains of amino acids, smaller and simpler in structure than proteins. While Dupixent may break down into peptides during its metabolic process, its active therapeutic form is not a peptide.An Interleukin-4 Receptor Antagonist for Atopic Dermatitis - PMC
* Proteins: These are larger, more complex molecules made up of long chains of amino acids. Antibodies are a specific type of protein.DUPIXENT (dupilumab) Injection is ... As a human monoclonal. IgG4 antibody,dupilumab is expected to be degraded into small peptidesand amino acids.
* Monoclonal Antibodies: These are highly targeted proteins produced by a single type of immune cell (a clone). They are designed to recognize and bind to a specific antigen or target molecule, such as the IL-4 receptor alpha. Dupixent is a prime example of a monoclonal antibody used in targeted therapyDupixent Approved for Moderate-to-Severe Atopic Dermatitis.
* Biologics: This is a broad category of medications derived from living organisms or their components. Monoclonal antibodies, like Dupixent, fall under the umbrella of biologics.
Therefore, while Dupixent is a biologic and a protein, its precise classification as a monoclonal antibody distinguishes it from simpler molecules like peptides.What type of medication is Dupixent (dupilumab)?
Dupixent is administered as a subcutaneous injection. Once in the body, it circulates and binds to the IL-4 receptor alpha subunit, preventing IL-4 and IL-13 from activating downstream signaling pathways that promote inflammation.2020年5月26日—Dupixent is a fully-human monoclonal antibodythat inhibits the signaling of the interleukin-4 (IL-4) and interleukin-13 (IL-13) proteins, and ... As a protein, Dupixent is eventually broken down by the body's natural catabolic processes. This degradation results in smaller components, including amino acids and small peptides. However, this breakdown occurs after the drug has exerted its therapeutic effect, and the drug's efficacy is attributed to its intact antibody structure, not its degraded peptide fragments.Dupilumab
Dupixent's mechanism of action makes it effective for a range of inflammatory conditions driven by type 2 immunity. Its primary indications include:
* Atopic Dermatitis (Eczema): For moderate-to-severe cases unresponsive to topical treatments.
* Asthma: As an add-on treatment for moderate-to-severe asthma with an eosinophilic phenotype or oral steroid-dependent asthma.DUPIXENT (dupilumab) Injection is ... As a human monoclonal. IgG4 antibody,dupilumab is expected to be degraded into small peptidesand amino acids.
* Chronic Rhinosinusitis with Nasal Polyps: For patients whose condition is not adequately controlled.
In summary, Dupixent (dupilumab) is a sophisticated biologic medication classified as a monoclonal antibody.dupilumab / Amino Acid, Peptide, or Protein While it is composed of amino acids and is expected to degrade into peptides and amino acids, its therapeutic action is entirely dependent on its intact antibody structure, which specifically targets key inflammatory signaling proteins. It is not a peptide in its functional or primary classification.Dupixent, INN-dupilumab - EMA
Join the newsletter to receive news, updates, new products and freebies in your inbox.